Mölnlycke Health Care secures USD 400 Million in financing from SEK to support global expansion strategy
Stockholm/Gothenburg – 24 June, 2025. Mölnlycke Health Care and The Swedish Export Credit Corporation (SEK) have signed a USD 400 million financing agreement to support the healthcare company’s continued global growth and development.
The ten-year financing facility from SEK will enable Mölnlycke to further expand its operations and accelerate strategic development initiatives globally.
Mölnlycke is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. The company develops, manufactures and sells products and solutions that are used daily by hospitals, healthcare providers and patients in over 100 countries around the world. With a strong global footprint, the company plays a critical role in advancing healthcare worldwide.
“We are very pleased to support Mölnlycke Health Care, an industry leader with a strong international presence and a key contributor to Swedish exports,” says Klas Lindgren Dansbo, Head of Large Corporates at SEK. “We’re proud to be part of their continued growth journey.”
“We have an exciting path ahead of us to navigate and support the evolving healthcare landscape. As we advance into the next phase of our customer centric strategy, our agreement with SEK marks a pivotal step in supporting our future growth,“ says Zlatko Rihter, CEO, Mölnlycke.
For more information please contact:
-
Jamie Smith, Media Relations Manager
jamie.smith@molnlycke.com
Phone +46 (0)723-757507 -
Katarina Daniels, Head of Communications
katarina.daniels@sek.se
Phone: +46 (0) 720 80 68 85
About SEK
The Swedish Export Credit Corporation (SEK) is a commercially driven, state-owned company that provides financing to Swedish exporters, their subcontractors, subsidiaries, and international buyers of Swedish products and services. SEK’s financing supports company growth, creating new jobs and driving economic growth in Sweden. Additionally, SEK promotes the transition to a more sustainable society, both within Sweden and globally.
About Mölnlycke
Mölnlycke Health Care is a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures. Mölnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries around the world. Founded in 1849, Mölnlycke is owned by Investor AB and headquartered in Sweden. www.molnlycke.com